Integrated BioPharma Inc (INBP) stock
INBPOTCPharmaceutical PreparationsFiscal year ends June 30
$0.18+0.00 (0.00%)
Close on Oct 19, 2026Market cap $5.59MP/E –Yield –
Integrated BioPharma total assets
Total assets on the balance sheet at the end of each period.
Integrated BioPharma's total assets was $25.34M at Jun 30, 2026. For fiscal 2026 it was $25.34M, up 1.8% from the year before. Over ten years it grew 6.2% a year on average. The highest annual figure on record is $26.21M in fiscal 2023.
Annual total assets
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2026 | Jun 30, 2026 | $25.34M | +1.8% |
| FY2025 | Jun 30, 2025 | $24.90M | -5.0% |
| FY2024 | Jun 30, 2024 | $26.21M | 0.0% |
| FY2023 | Jun 30, 2023 | $26.21M | +3.8% |
| FY2022 | Jun 30, 2022 | $25.25M | -0.7% |
| FY2021 | Jun 30, 2021 | $25.44M | +10.9% |
| FY2020 | Jun 30, 2020 | $22.94M | +15.9% |
| FY2019 | Jun 30, 2019 | $19.79M | +35.8% |
| FY2018 | Jun 30, 2018 | $14.57M | -4.1% |
| FY2017 | Jun 30, 2017 | $15.20M | +8.9% |
| FY2016 | Jun 30, 2016 | $13.95M | +20.0% |
| FY2015 | Jun 30, 2015 | $11.62M | +0.3% |
| FY2014 | Jun 30, 2014 | $11.58M | -8.2% |
| FY2013 | Jun 30, 2013 | $12.61M | +6.2% |
| FY2012 | Jun 30, 2012 | $11.88M | -13.0% |
| FY2011 | Jun 30, 2011 | $13.65M | – |
Quarterly total assets
Change is against the same quarter a year earlier.
Periods
| Period | Period end | Value | Change |
|---|---|---|---|
| Q4 FY2026CQ2 2026 | Jun 30, 2026 | $25.34M | +1.8% |
| Q3 FY2026CQ1 2026 | Mar 31, 2026 | $26.67M | +3.9% |
| Q2 FY2026CQ4 2025 | Dec 31, 2025 | $23.55M | -8.2% |
| Q1 FY2026CQ3 2025 | Sep 30, 2025 | $25.54M | -2.5% |
| Q4 FY2025CQ2 2025 | Jun 30, 2025 | $24.90M | -5.0% |
| Q3 FY2025CQ1 2025 | Mar 31, 2025 | $25.66M | -4.8% |
| Q2 FY2025CQ4 2024 | Dec 31, 2024 | $25.66M | -0.2% |
| Q1 FY2025CQ3 2024 | Sep 30, 2024 | $26.18M | -1.7% |
| Q4 FY2024CQ2 2024 | Jun 30, 2024 | $26.21M | 0.0% |
| Q3 FY2024CQ1 2024 | Mar 31, 2024 | $26.94M | +0.2% |
| Q2 FY2024CQ4 2023 | Dec 31, 2023 | $25.72M | -1.3% |
| Q1 FY2024CQ3 2023 | Sep 30, 2023 | $26.64M | +1.1% |
| Q4 FY2023CQ2 2023 | Jun 30, 2023 | $26.21M | +3.8% |
| Q3 FY2023CQ1 2023 | Mar 31, 2023 | $26.88M | -2.9% |
| Q2 FY2023CQ4 2022 | Dec 31, 2022 | $26.05M | -3.8% |
| Q1 FY2023CQ3 2022 | Sep 30, 2022 | $26.36M | +8.3% |
| Q4 FY2022CQ2 2022 | Jun 30, 2022 | $25.25M | -0.7% |
| Q3 FY2022CQ1 2022 | Mar 31, 2022 | $27.70M | +6.0% |
| Q2 FY2022CQ4 2021 | Dec 31, 2021 | $27.07M | +7.2% |
| Q1 FY2022CQ3 2021 | Sep 30, 2021 | $24.34M | -1.2% |
| Q4 FY2021CQ2 2021 | Jun 30, 2021 | $25.44M | +10.9% |
| Q3 FY2021CQ1 2021 | Mar 31, 2021 | $26.13M | +26.6% |
| Q2 FY2021CQ4 2020 | Dec 31, 2020 | $25.26M | +26.5% |
| Q1 FY2021CQ3 2020 | Sep 30, 2020 | $24.63M | +25.4% |
| Q4 FY2020CQ2 2020 | Jun 30, 2020 | $22.94M | +15.9% |
| Q3 FY2020CQ1 2020 | Mar 31, 2020 | $20.65M | -7.1% |
| Q2 FY2020CQ4 2019 | Dec 31, 2019 | $19.97M | -11.5% |
| Q1 FY2020CQ3 2019 | Sep 30, 2019 | $19.64M | -0.4% |
| Q4 FY2019CQ2 2019 | Jun 30, 2019 | $19.79M | +35.8% |
| Q3 FY2019CQ1 2019 | Mar 31, 2019 | $22.22M | +52.0% |
| Q2 FY2019CQ4 2018 | Dec 31, 2018 | $22.58M | +44.3% |
| Q1 FY2019CQ3 2018 | Sep 30, 2018 | $19.72M | +47.4% |
| Q4 FY2018CQ2 2018 | Jun 30, 2018 | $14.57M | -4.1% |
| Q3 FY2018CQ1 2018 | Mar 31, 2018 | $14.62M | +7.4% |
| Q2 FY2018CQ4 2017 | Dec 31, 2017 | $15.65M | +4.3% |
| Q1 FY2018CQ3 2017 | Sep 30, 2017 | $13.38M | -8.6% |
| Q4 FY2017CQ2 2017 | Jun 30, 2017 | $15.20M | – |
| Q3 FY2017CQ1 2017 | Mar 31, 2017 | $13.61M | – |
| Q2 FY2017CQ4 2016 | Dec 31, 2016 | $15.00M | – |
| Q1 FY2017CQ3 2016 | Sep 30, 2016 | $14.65M | – |
See a number that looks wrong?